292 related articles for article (PubMed ID: 33401401)
1. Microbiota-Mediated Immune Regulation in Atherosclerosis.
Eshghjoo S; Jayaraman A; Sun Y; Alaniz RC
Molecules; 2021 Jan; 26(1):. PubMed ID: 33401401
[TBL] [Abstract][Full Text] [Related]
2. Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis.
Yeh CF; Chen YH; Liu SF; Kao HL; Wu MS; Yang KC; Wu WK
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33227973
[TBL] [Abstract][Full Text] [Related]
3. Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis.
Liu Y; Dai M
Mediators Inflamm; 2020; 2020():4634172. PubMed ID: 32148438
[TBL] [Abstract][Full Text] [Related]
4. Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: role of tryptophan metabolites generated by gut host-microbiota.
Salminen A
J Mol Med (Berl); 2023 Mar; 101(3):201-222. PubMed ID: 36757399
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide.
Zhu Y; Li Q; Jiang H
APMIS; 2020 May; 128(5):353-366. PubMed ID: 32108960
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota and Atherosclerosis.
Li DY; Tang WHW
Curr Atheroscler Rep; 2017 Aug; 19(10):39. PubMed ID: 28842845
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Immune Responses by Nutritional Ligands of Aryl Hydrocarbon Receptor.
De Juan A; Segura E
Front Immunol; 2021; 12():645168. PubMed ID: 34093534
[TBL] [Abstract][Full Text] [Related]
8. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
McLaren JE; Michael DR; Ashlin TG; Ramji DP
Prog Lipid Res; 2011 Oct; 50(4):331-47. PubMed ID: 21601592
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota, Atherosclerosis, and Therapeutic Targets.
Mantziaris V; Kolios G
Crit Pathw Cardiol; 2019 Sep; 18(3):139-142. PubMed ID: 31348074
[TBL] [Abstract][Full Text] [Related]
11. Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity.
Dong F; Hao F; Murray IA; Smith PB; Koo I; Tindall AM; Kris-Etherton PM; Gowda K; Amin SG; Patterson AD; Perdew GH
Gut Microbes; 2020 Nov; 12(1):1-24. PubMed ID: 32783770
[TBL] [Abstract][Full Text] [Related]
12. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation.
Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021
[TBL] [Abstract][Full Text] [Related]
13. The aryl hydrocarbon receptor as a mediator of host-microbiota interplay.
Dong F; Perdew GH
Gut Microbes; 2020 Nov; 12(1):1859812. PubMed ID: 33382356
[TBL] [Abstract][Full Text] [Related]
14. Aryl hydrocarbon receptor connects dysregulated immune cells to atherosclerosis.
Wang F; Liang S; Hu J; Xu Y
Immunol Lett; 2020 Dec; 228():55-63. PubMed ID: 33053378
[TBL] [Abstract][Full Text] [Related]
15. Emerging roles of xenobiotic detoxification enzymes in metabolic diseases.
Petriello MC; Hoffman JB; Morris AJ; Hennig B
Rev Environ Health; 2017 Mar; 32(1-2):105-110. PubMed ID: 27837601
[TBL] [Abstract][Full Text] [Related]
16. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.
Koeth RA; Lam-Galvez BR; Kirsop J; Wang Z; Levison BS; Gu X; Copeland MF; Bartlett D; Cody DB; Dai HJ; Culley MK; Li XS; Fu X; Wu Y; Li L; DiDonato JA; Tang WHW; Garcia-Garcia JC; Hazen SL
J Clin Invest; 2019 Jan; 129(1):373-387. PubMed ID: 30530985
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota in Hypertension and Atherosclerosis: A Review.
Verhaar BJH; Prodan A; Nieuwdorp M; Muller M
Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003455
[TBL] [Abstract][Full Text] [Related]
18. A Multi-omic Association Study of Trimethylamine N-Oxide.
Manor O; Zubair N; Conomos MP; Xu X; Rohwer JE; Krafft CE; Lovejoy JC; Magis AT
Cell Rep; 2018 Jul; 24(4):935-946. PubMed ID: 30044989
[TBL] [Abstract][Full Text] [Related]
19. Aryl Hydrocarbon Receptor and Uremic Toxins from the Gut Microbiota in Chronic Kidney Disease Patients: Is There a Relationship between Them?
Brito JS; Borges NA; Anjos JSD; Nakao LS; Stockler-Pinto MB; Paiva BR; Cardoso-Weide LC; Cardozo LFMF; Mafra D
Biochemistry; 2019 Apr; 58(15):2054-2060. PubMed ID: 30912928
[TBL] [Abstract][Full Text] [Related]
20. Role of S-Equol, Indoxyl Sulfate, and Trimethylamine N-Oxide on Vascular Function.
Matsumoto T; Kojima M; Takayanagi K; Taguchi K; Kobayashi T
Am J Hypertens; 2020 Sep; 33(9):793-803. PubMed ID: 32300778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
